Jeremy R W, Koretsune Y, Marban E, Becker L C
Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, Md.
Circ Res. 1992 Jun;70(6):1180-90. doi: 10.1161/01.res.70.6.1180.
This study examined the hypothesis that glycolysis is required for functional recovery of the myocardium during reperfusion by facilitating restoration of calcium homeostasis. [Ca2+]i was measured in isolated perfused rabbit hearts by using the Ca2+ indicator 1,2-bis(2-amino-5-fluorophenoxy)ethane-N,N,N',N'-tetraacetic acid (5F-BAPTA) and 19F nuclear magnetic resonance spectroscopy. In nonischemic control hearts, inhibition of glycolysis with iodoacetate did not alter [Ca2+]i. In hearts subjected to 20 minutes of global zero-flow ischemia, [Ca2+]i increased from 260 +/- 80 nM before ischemia to 556 +/- 44 nM after 15 minutes of ischemia (p less than 0.05). After reperfusion with 5 mM pyruvate as a carbon substrate, [Ca2+]i increased further in hearts with intact glycolysis to 851 +/- 134 nM (p less than 0.05 versus ischemia) during the first 10 minutes of reperfusion, before returning to preischemic levels. In contrast, inhibition of glycolysis during the reperfusion period resulted in persistent severe calcium overload ([Ca2+]i, 1,380 +/- 260 nM after 15 minutes of reperfusion, p less than 0.02 versus intact glycolysis group). Furthermore, despite the presence of pyruvate and oxygen, inhibition of glycolysis during early reperfusion resulted in greater impairment of functional recovery (rate/pressure product, 3,722 +/- 738 mm Hg/min) than did reperfusion with pyruvate and intact glycolysis (rate/pressure product, 9,851 +/- 590 mm Hg/min, p less than 0.01). Inhibition of glycolysis during early reperfusion was also associated with a marked increase in left ventricular end-diastolic pressure during reperfusion (41 +/- 5 mm Hg) compared with hearts with intact glycolysis (16 +/- 2 mm Hg, p less than 0.01). The detrimental effects of glycolytic inhibition during early reperfusion were, however, prevented by initial reperfusion with a low calcium solution ([Ca]o, 0.63 mM for 30 minutes, then 2.50 mM for 30 minutes). In these hearts, the rate/pressure product after 60 minutes of reperfusion was 12,492 +/- 1,561 mm Hg/min (p less than 0.01 versus initial reflow with [Ca]o of 2.50 mM). These findings indicate that the functional impairment observed in postischemic myocardium is related to cellular Ca2+ overload. Glycolysis appears to play an important role in restoration of Ca2+ homeostasis and recovery of function of postischemic myocardium.
糖酵解通过促进钙稳态的恢复,对于再灌注期间心肌的功能恢复是必需的。通过使用钙离子指示剂1,2-双(2-氨基-5-氟苯氧基)乙烷-N,N,N',N'-四乙酸(5F-BAPTA)和19F核磁共振波谱法,在离体灌注兔心脏中测量[Ca2+]i。在非缺血对照心脏中,用碘乙酸抑制糖酵解不会改变[Ca2+]i。在经历20分钟全心零流量缺血的心脏中,[Ca2+]i从缺血前的260±80 nM增加到缺血15分钟后的556±44 nM(p<0.05)。以5 mM丙酮酸作为碳底物进行再灌注后,在再灌注的最初10分钟内,糖酵解完整的心脏中的[Ca2+]i进一步增加至851±134 nM(p<0.05,与缺血时相比),然后恢复到缺血前水平。相比之下,在再灌注期间抑制糖酵解会导致持续严重的钙超载(再灌注15分钟后[Ca2+]i为1,380±260 nM,与糖酵解完整组相比,p<0.02)。此外,尽管存在丙酮酸和氧气,但在再灌注早期抑制糖酵解导致的功能恢复受损(速率/压力乘积为3,722±738 mmHg/min)比用丙酮酸和完整糖酵解进行再灌注(速率/压力乘积为9,851±590 mmHg/min,p<0.01)更严重。与糖酵解完整的心脏(16±2 mmHg,p<0.01)相比,再灌注早期抑制糖酵解还与再灌注期间左心室舒张末期压力显著增加(41±5 mmHg)有关。然而,通过用低钙溶液([Ca]o,0.63 mM持续30分钟,然后2.50 mM持续30分钟)进行初始再灌注,可以预防再灌注早期糖酵解抑制的有害影响。在这些心脏中,再灌注60分钟后的速率/压力乘积为12,492±1,561 mmHg/min(p<0.01,与[Ca]o为2.50 mM的初始再灌注相比)。这些发现表明,缺血后心肌中观察到的功能损害与细胞内Ca2+超载有关。糖酵解似乎在缺血后心肌的Ca2+稳态恢复和功能恢复中起重要作用。